Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenicsâ€™ lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.
Funding Rounds (2) - $43MUpdate
Procter & Gamble is an American multinational consumer goods company offering personal care...
Venture Capital Firm
For 30 years the Mohr Davidow Ventures (MDV) team has invested in early stage technology-based...
Google is a search and advertising service provider that aims to organize and monetize the...
1001 E. Hillsdale Blvd
Foster City, CA 94404
23andMe is a human genome research company enabling users to study their ancestry, genealogy, and...
- 05/04/09 -techcrunch.com